We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,623 hedge funds and large institutions have $295B invested in Johnson & Johnson in 2022 Q3 according to their latest regulatory filings, with 115 funds opening new positions, 1,691 increasing their positions, 1,445 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $3.67B | Put options by funds: $2.74B

17% more repeat investments, than reductions

Existing positions increased: 1,691 | Existing positions reduced: 1,445

0.2% less ownership

Funds ownership: 69.11%68.92% (-0.2%)

2% less first-time investments, than exits

New positions opened: 115 | Existing positions closed: 117

1% less funds holding

Funds holding: 3,6723,623 (-49)

6% less funds holding in top 10

Funds holding in top 10: 773730 (-43)

8% less capital invested

Capital invested by funds: $321B → $295B (-$26.2B)

Holders
3,623
Holders Change
-49
Holders Change %
-1.33%
% of All Funds
62.4%
Holding in Top 10
730
Holding in Top 10 Change
-43
Holding in Top 10 Change %
-5.56%
% of All Funds
12.57%
New
115
Increased
1,691
Reduced
1,445
Closed
117
Calls
$3.67B
Puts
$2.74B
Net Calls
+$925M
Net Calls Change
+$91.9M
Name Holding Trade Value Shares
Change
Change in
Stake
NPA
251
Nichols & Pratt Advisers
Massachusetts
$86.6M -$3.36M -19,880 -4%
NONA
252
Ninety One North America
New York
$86.1M -$1.58M -9,321 -2%
NAM
253
Nissay Asset Management
Japan
$85.5M +$18M +106,319 +25%
OAM
254
Oppenheimer Asset Management
New York
$85.5M +$5.9M +34,893 +7%
MVIP
255
Mar Vista Investment Partners
California
$85.5M -$44.8K -265 -0.1%
BNP Paribas Financial Markets
256
BNP Paribas Financial Markets
France
$84.2M -$41.4M -244,777 -32%
Cambridge Investment Research Advisors
257
Cambridge Investment Research Advisors
Iowa
$83.6M +$1.58M +9,340 +2%
Cerity Partners
258
Cerity Partners
New York
$81.9M -$50.8K -300 -0.1%
CS
259
Candriam SCA
Luxembourg
$81M -$24.7M -145,989 -23%
PGFC
260
Peapack-Gladstone Financial Corp
New Jersey
$80.8M +$15.1M +89,435 +22%
SIG
261
Stonegate Investment Group
Alabama
$80.1M +$445K +2,630 +0.5%
CCMG
262
Clark Capital Management Group
Pennsylvania
$79.5M -$5.45M -32,227 -6%
MHI
263
Miller Howard Investments
New York
$79.4M -$1.89M -11,197 -2%
LGF
264
LGT Group Foundation
Liechtenstein
$79.4M -$7.4M -43,759 -8%
PI
265
PineBridge Investments
New York
$77.6M -$1.17M -6,908 -1%
TCIM
266
TOMS Capital Investment Management
New York
$77.4M +$80.2M +473,840 New
URS
267
Utah Retirement Systems
Utah
$77.1M +$389K +2,300 +0.5%
ERSOT
268
Employees Retirement System of Texas
Texas
$76.8M +$146K +864 +0.2%
CAG
269
Crestwood Advisors Group
Massachusetts
$76.7M +$1.73M +10,195 +2%
Federated Hermes
270
Federated Hermes
Pennsylvania
$75.8M -$8.31M -49,124 -10%
II
271
IFM Investors
Australia
$75.5M +$2.55M +15,053 +3%
Mercer Global Advisors
272
Mercer Global Advisors
Colorado
$75.4M +$8.13M +48,035 +12%
TF
273
TIAA FSB
Florida
$74.5M +$1.53M +9,027 +2%
GIBU
274
Gulf International Bank (UK)
United Kingdom
$74.2M +$1.52M +8,999 +2%
MAM
275
Martingale Asset Management
Massachusetts
$73.8M -$1.79M -10,585 -2%

JNJ Hedge Fund Activity: Q3 2022 in Review

3,623 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2022, worth a combined $295B — down 8.2% from $321B a quarter earlier.

Sellers outnumbered buyers: 117 funds closed out of JNJ and 115 opened new positions — a net loss of 2 holders — while 1,445 trimmed existing stakes and 1,691 added.

The largest buyer was Amundi, adding an estimated $572M. The largest seller was BlackRock, cutting an estimated $933M.

  • 3,623 institutional investors held Johnson & Johnson (JNJ) as of Q3 2022, down from 3,672 in Q2 2022.
  • Funds reported $295B of Johnson & Johnson stock for Q3 2022, down 8.2% quarter-over-quarter.
  • 115 funds opened new Johnson & Johnson positions in Q3 2022 and 117 closed out, a net change of -2 holders.
  • The largest Johnson & Johnson buyer in Q3 2022 was Amundi, an estimated $572M added.
  • The largest Johnson & Johnson seller in Q3 2022 was BlackRock, an estimated $933M sold.

Based on aggregated 13F filings for Q3 2022.